ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Purespring Therapeutics Limited

Purespring Therapeutics Limited is an active company incorporated on 1 April 2020 with the registered office located in London, Greater London. Purespring Therapeutics Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12543677
Private limited company
Age
5 years
Incorporated 1 April 2020
Size
Large
Balance sheet is over £27M
Confirmation
Submitted
Dated 31 March 2025 (9 months ago)
Next confirmation dated 31 March 2026
Due by 14 April 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
8 Bloomsbury Street
London
WC1B 3SR
England
Same address since incorporation
Telephone
020 38556324
Email
Unreported
People
Officers
7
Shareholders
53
Controllers (PSC)
1
Director • Venture Capitalist • British • Lives in UK • Born in Feb 1972
Director • Financial Investor • Czech • Lives in Netherlands • Born in Jul 1987
Director • Chief Executive Officer • British • Lives in UK • Born in Mar 1976
Director • Ceo • British • Lives in England • Born in Sep 1968
Director • Physician Scientist • American • Lives in Switzerland • Born in Sep 1967
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Myricx Pharma Limited
Maina Bhaman is a mutual person.
Active
Forcefield Therapeutics Limited
Dr John Tsai is a mutual person.
Active
Elevara Medicines Limited
Maina Bhaman is a mutual person.
Active
Touchstone Innovations Businesses LLP
Maina Bhaman is a mutual person.
Active
Kesios Therapeutics Limited
Maina Bhaman is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£28.02M
Increased by £17.61M (+169%)
Turnover
Unreported
Same as previous period
Employees
46
Increased by 1 (+2%)
Total Assets
£34M
Increased by £19.13M (+129%)
Total Liabilities
-£4.22M
Decreased by £8.68M (-67%)
Net Assets
£29.78M
Increased by £27.8M (+1402%)
Debt Ratio (%)
12%
Decreased by 74.27% (-86%)
Latest Activity
Dr Christopher John Hollowood Appointed
2 Months Ago on 7 Nov 2025
Michael Kyriakides Resigned
2 Months Ago on 7 Nov 2025
Arthur Lodewijk Franken Resigned
4 Months Ago on 2 Sep 2025
Haseeb Ahmad Appointed
8 Months Ago on 20 May 2025
Small Accounts Submitted
8 Months Ago on 2 May 2025
Confirmation Submitted
9 Months Ago on 15 Apr 2025
Julian Hanak Resigned
10 Months Ago on 1 Mar 2025
Small Accounts Submitted
1 Year Ago on 24 Dec 2024
Arthur Lodewijk Franken Appointed
1 Year 1 Month Ago on 6 Dec 2024
Mr. Michael Kyriakides Details Changed
1 Year 7 Months Ago on 24 May 2024
Get Credit Report
Discover Purespring Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 12 December 2025
Submitted on 17 Dec 2025
Statement of capital following an allotment of shares on 4 September 2025
Submitted on 15 Dec 2025
Termination of appointment of Arthur Lodewijk Franken as a director on 2 September 2025
Submitted on 18 Nov 2025
Appointment of Dr Christopher John Hollowood as a director on 7 November 2025
Submitted on 14 Nov 2025
Termination of appointment of Michael Kyriakides as a director on 7 November 2025
Submitted on 14 Nov 2025
Resolutions
Submitted on 17 Sep 2025
Appointment of Haseeb Ahmad as a director on 20 May 2025
Submitted on 15 Sep 2025
Termination of appointment of Julian Hanak as a director on 1 March 2025
Submitted on 2 Sep 2025
Accounts for a small company made up to 31 December 2024
Submitted on 2 May 2025
Director's details changed for Mr. Michael Kyriakides on 24 May 2024
Submitted on 15 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year